Showing 1 - 5 results of 5 for search 'Norbert Heinrich', query time: 0.01s Refine Results
  1. 1
    A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB.

    A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB. by Markus Beutler, Sara Plesnik, Marina Mihalic, Laura Olbrich, Norbert Heinrich, Samuel Schumacher, Michael Lindner, Ina Koch, Wolfgang Grasse, Christoph Metzger-Boddien, Sabine Hofmann-Thiel, Harald Hoffmann

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings.

    Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings. by Edson Tawanda Marambire, Claire J Calderwood, Leyla Larsson, Kathrin Held, Palwasha Khan, Denise Banze, Celina Nhamuave, Lillian T Minja, Alfred Mfinanga, Rishi K Gupta, Celso Khosa, Junior Mutsvangwa, Norbert Heinrich, Katharina Kranzer

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials

    Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials by Andrew R. DiNardo, Andrew R. DiNardo, Wilbert Sabiiti, Stephen H. Gillespie, Sophia B. Georghiou, Norbert Heinrich, Norbert Heinrich, Norbert Hittel, Sami Taghlabi, Danna Carrero Longlax, Mikashmi Kohli, Ursula Panzner, Ursula Panzner, Collins Musia, Christoph Lange, Christoph Lange, Christoph Lange, Christoph Lange, Anca Vasiliu, Anca Vasiliu, Anca Vasiliu, Rob J. W. Arts, Anna M. Mandalakas, Anna M. Mandalakas, Anna M. Mandalakas, Morten Ruhwald, Lieven J. Stuyver, Reinout van Crevel, Reinout van Crevel

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis

    DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis by Nestani Tukvadze, Sehlomola Mashatole, Anne Jacobs, Tlhago Ngwanto, Norbert Heinrich, Annelies Van Rie, Valeriu Crudu, Elena Tudor, Leila Goginashvili, Elmira Ibraim, Celso Khosa, Pauline Howell, Shakira Rajaram, Kinita Naidoo, Stefan Niemann, Klaus Reither, Robert S. Wallis

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus.

    Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expe... by Sabine Dittrich, Birkneh Tilahun Tadesse, Francis Moussy, Arlene Chua, Anna Zorzet, Thomas Tängdén, David L Dolinger, Anne-Laure Page, John A Crump, Valerie D'Acremont, Quique Bassat, Yoel Lubell, Paul N Newton, Norbert Heinrich, Timothy J Rodwell, Iveth J González

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: